STORY SUMMARY

Doctor reacts to AI breast cancer tool

The providers of Clairity Breast, a new FDA-approved AI tool, claim their tech provides an accurate five-year risk assessment for breast cancer, for just $249. Dr. Céline Gounder shares her thoughts.

This is a brief summary of reporting from CBS News Technology. Read the original for the full article and context.

Read original reporting ↗

More from CBS News Technology · Latest headlines